Aspen Aerogels, Inc. (NYSE:ASPN) CFO Sells $978,495.10 in Stock

Aspen Aerogels, Inc. (NYSE:ASPN) CFO Ricardo C. Rodriguez sold 32,465 shares of the firm’s stock in a transaction that occurred on Monday, August 26th. The shares were sold at an average price of $30.14, for a total transaction of $978,495.10. Following the completion of the transaction, the chief financial officer now owns 20,790 shares of the company’s stock, valued at $626,610.60. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website.

Aspen Aerogels Price Performance

Shares of ASPN stock traded down $1.24 during trading hours on Wednesday, hitting $28.68. 1,125,200 shares of the company’s stock were exchanged, compared to its average volume of 1,278,905. The company has a market capitalization of $2.18 billion, a PE ratio of -68.00 and a beta of 2.15. Aspen Aerogels, Inc. has a 12-month low of $5.70 and a 12-month high of $33.15. The business’s 50 day simple moving average is $24.57 and its 200-day simple moving average is $22.13. The company has a current ratio of 4.01, a quick ratio of 3.29 and a debt-to-equity ratio of 0.24.

Aspen Aerogels (NYSE:ASPN) last issued its earnings results on Wednesday, August 7th. The construction company reported $0.21 EPS for the quarter, topping the consensus estimate of $0.05 by $0.16. Aspen Aerogels had a negative net margin of 10.73% and a negative return on equity of 6.35%. The company had revenue of $117.80 million for the quarter, compared to the consensus estimate of $101.99 million. During the same period in the previous year, the firm earned ($0.22) earnings per share. The firm’s revenue for the quarter was up 144.4% on a year-over-year basis. On average, equities research analysts anticipate that Aspen Aerogels, Inc. will post 0.12 earnings per share for the current year.

Analyst Ratings Changes

Several equities research analysts have issued reports on ASPN shares. Benchmark reiterated a “buy” rating and set a $14.00 target price on shares of Aspen Aerogels in a research report on Thursday, August 8th. Canaccord Genuity Group lifted their target price on shares of Aspen Aerogels from $18.00 to $28.00 and gave the company a “buy” rating in a research report on Friday, May 3rd. Piper Sandler lifted their target price on shares of Aspen Aerogels from $30.00 to $36.00 and gave the company an “overweight” rating in a research report on Wednesday, May 29th. HC Wainwright lifted their target price on shares of Aspen Aerogels from $25.00 to $30.00 and gave the company a “buy” rating in a research report on Friday, August 9th. Finally, Roth Mkm reiterated a “buy” rating and set a $36.00 target price on shares of Aspen Aerogels in a research report on Wednesday, August 21st. One equities research analyst has rated the stock with a sell rating, nine have issued a buy rating and one has given a strong buy rating to the company. According to data from MarketBeat, the company presently has a consensus rating of “Moderate Buy” and a consensus price target of $29.70.

Institutional Inflows and Outflows

Hedge funds have recently made changes to their positions in the company. Banque Cantonale Vaudoise increased its stake in shares of Aspen Aerogels by 37.5% in the first quarter. Banque Cantonale Vaudoise now owns 4,593 shares of the construction company’s stock worth $81,000 after buying an additional 1,252 shares during the period. Point72 Hong Kong Ltd purchased a new position in Aspen Aerogels during the 2nd quarter valued at $84,000. nVerses Capital LLC purchased a new position in Aspen Aerogels during the 2nd quarter valued at $95,000. Point72 DIFC Ltd purchased a new position in Aspen Aerogels during the 2nd quarter valued at $121,000. Finally, Public Employees Retirement Association of Colorado purchased a new position in Aspen Aerogels during the 2nd quarter valued at $145,000. 97.64% of the stock is owned by hedge funds and other institutional investors.

Aspen Aerogels Company Profile

Aspen Aerogels, Inc designs, develops, manufactures, and sells aerogel insulation products primarily for use in the energy infrastructure and sustainable insulation materials markets in the United States, Asia, Canada, Europe, and Latin America. It operates in two segments, Energy Industrial and Thermal Barrier.